ArticleInternational immunology2015

In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.

Andre P da Cunha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.